AbbVie (NYSE:ABBV) is set to report its Q2 earnings on Thursday, July 31, before the market opens. Analysts are expecting earnings per share of $2.91, reflecting a 9.8% year-over-year increase, with ...

Biogen said it will incur a $46M charge in its Q2 results leading to a ($0.26) impact in its GAAP and non-GAAP EPS due to acquired in-process research and development (IPR&D), upfront, and milestone ...